Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland - Investors in Healthcare
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland Investors in Healthcare
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland - Yahoo Finance Australia
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland Yahoo Finance Australia
Agilent Technologies, Inc. $A Shares Acquired by DNB Asset Management AS - MarketBeat
Agilent Technologies, Inc. $A Shares Acquired by DNB Asset Management AS MarketBeat
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights - MedTech Intelligence
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights MedTech Intelligence
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B MedTech Dive
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - Business Wire
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights Business Wire
Lonza to Acquire Redberry SAS - Contract Pharma
Lonza to Acquire Redberry SAS Contract Pharma
Why Top Investors Are Buying Thermo Fisher Scientific Inc. (TMO) - The Acquirer's Multiple
Why Top Investors Are Buying Thermo Fisher Scientific Inc. (TMO) The Acquirer's Multiple
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters